Showing results (131-140 of 323) with videos related to

Sort By:
Pageof 33
Pharmacoepidemiology and Drug Safety|July 22, 2021
Method used to identify adenomyosis and potentially undiagnosed adenomyosis in a large, U.S. electronic health record databaseAnita M Loughlin, Stephanie E Chiuve, Gally Reznor, et al.
Annals of the Rheumatic Diseases|January 29, 2013
The genetic contribution to severe post-traumatic osteoarthritisAna M Valdes, Sally A Doherty, Kenneth R Muir, et al.
Arthritis and Rheumatism|December 30, 2006
Sex and ethnic differences in the association of ASPN, CALM1, COL2A1, COMP, and FRZB with genetic susceptibility to osteoarthritis of the kneeAna M Valdes, John Loughlin, Mark Van Oene, et al.
BMJ Open|January 29, 2024
Secular trend of gout incidence in the UK: an age-period-cohort analysisJing Ye, Yuqing Zhang, Weiya Zhang, et al.
Arthritis Care & Research|June 25, 2019
Natural History of Radiographic First Metatarsophalangeal Joint Osteoarthritis: A Nineteen-Year Population-Based Cohort StudyCatherine Bowen, Lucy Gates, Peter McQueen, et al.
Annals of the Rheumatic Diseases|May 27, 2011
Nottingham knee osteoarthritis risk prediction modelsWeiya Zhang, Daniel F McWilliams, Sarah L Ingham, et al.
Rheumatology (Oxford, England)|August 28, 2012
A systematic review of evidence for the effectiveness of practitioner-based complementary and alternative therapies in the management of rheumatic diseases: osteoarthritisGary J Macfarlane, Priya Paudyal, Michael Doherty, et al.
Rheumatology Advances in Practice|November 21, 2022
Feasibility of conducting a randomized, placebo-controlled study assessing whether omega-3 fatty acids prevent gout flares when starting urate-lowering treatmentAbhishek Abhishek, Amy Fuller, Georgina Nakafero, et al.
Rheumatology (Oxford, England)|June 5, 2012
A systematic review of evidence for the effectiveness of practitioner-based complementary and alternative therapies in the management of rheumatic diseases: rheumatoid arthritisGary J Macfarlane, Priya Paudyal, Michael Doherty, et al.
Health Economics|September 26, 2007
A comparison of the performance of the EQ-5D and SF-6D for individuals aged >or= 45 yearsGarry R Barton, Tracey H Sach, Anthony J Avery, et al.
Pageof 33